Compare3 funds · 3 pairs
Picked · 3YTD
Every pair · 3Won · shared
Close to theseFee · YTD
Best of the threeNov 4
  • Lowest cost$ a year on $10kSPYM 0.02%
  • Most incometrailing 12-month yieldBBC 1.50%
  • Best 5 yearsper yearSPYM +12.6%
  • Smallest drop · 1Yworst fall in the past yearIVV −8.9%
Measures won2–4SPYM wins · of 6 · 5Y
$10,000 · 5Y$18,126SPYM · IVV $18,118
Lowest cost0.02%SPYM · $2 on $10k
Most income1.50%BBC · $150 on $10k
Smallest drop−8.9%IVV · worst fall in 1Y
Held in common0.0%BBC and SPYM

BBC vs SPYM

5Y
BBC
SPYM
Virtus Biotech Clinical Trials ETF · $34MState Street SPDR Portfolio S&P 500 ETF · $182B
+37.4%3 years · per year$25,933 · $19,186+24.3%
+0.6%5 years · per year$10,290 · $18,126+12.6%
0.65%Expense ratio$65 · $2 on $10k · lower wins0.02%
1.50%12-mo yield$150 · $101 on $10k1.01%
−30.2%Worst dropSmaller wins−8.9%
37.6%VolatilityLower wins12.8%
2–4SPYM wins
$10,000 · 5 yearsAll three, one scale
$10k startSPYM $18.1kIVV $18.1kBBC $10.3kOct 2021Nov 2026
Shared top holdingsBBC · SPYM

They share no top holdings, or holdings aren’t on file […]

Held in common0.0%
End-of-day Nov 4, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

All Three

5Y3 funds
#Trend
1BSPYMState Street SPDR Portfolio S&P 500 ETFReadDesk0.02%1.01%+1.7%+13.4%+13.5%+24.3%+12.6%−8.9%$181.7B
2IVViShares Core S&P 500 ETFReadDesk0.03%1.09%+1.6%+13.4%+13.5%+24.2%+12.6%−8.9%$886.8B
3ABBCVirtus Biotech Clinical Trials ETFReadDesk0.65%1.50%+1.9%+13.1%+43.3%+37.4%+0.6%−30.2%$34M
End-of-day Nov 4, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

BBC vs SPYM

5Y
Virtus Biotech Clinical Trials
$10,290
SPDR Portfolio S&P 500
$18,126
$5k$10k$15kNov 2021Nov 2026$10,290$18,126$5k$10k$15kNov 2021Nov 2026$10,290$18,126
MeasureBBCSPYM
Fee0.65%0.02%
Cost on $10k a year$65$2
Yield1.50%1.01%
5 years, per year+0.6%+12.6%
3 years, per year+37.4%+24.3%
Worst drop · 1Y−30.2%−8.9%
Volatility · 1Y37.6%12.8%
4–2measures won
SPYM first
0.0%
holdings shared
Nov 4, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SPYM vs SPY

YTD
SPDRSPYM
+13.4%
SPYSPDR
+13.3%
Jan 1Nov 4+13.4%+13.3%
+13.4%Year to date+13.3%
1.0%Yield1.0%
$182BAssets$805B
1–0SPYM wins
End-of-day Nov 4, 2026
@TheETFTracker·theetftracker.com

VOO vs IVV

YTD
VanguardVOO
+13.4%
IVViShares
+13.4%
Jan 1Nov 4+13.4%+13.4%
+13.4%Year to date+13.4%
1.1%Yield1.1%
$1.00TAssets$887B
0–0level
End-of-day Nov 4, 2026
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+35.3%
VIGVanguard
+16.4%
Jan 1Nov 4+35.3%+16.4%
+35.3%Year to date+16.4%
2.9%Yield1.4%
$123BAssets$109B
2–0SCHD wins
End-of-day Nov 4, 2026
@TheETFTracker·theetftracker.com

Overlap: BBC, SPYM, IVV

Today
99.8%most shared, SPYM and IVV
BBCSPYMIVV
BBC—0.0%0.0%
SPYM0.0%—99.8%
IVV0.0%99.8%—
End-of-day Nov 4, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$106most kept, IVV
IVV$109 − $3 = $106
SPYM$101 − $2 = $99
BBC$150 − $65 = $85
KeptFee
End-of-day Nov 4, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com